由于新型分析工具的应用,中药研发再次出现热潮。近几年来,制药企业已经从开发专门针对引起某种疾病的单个分子的“重磅炸弹”药物,转向开发由多种活性成分组成的“复方”药物。虽然有人仍在致力于研究将传统的药物进行组合,但也有一部分研究者带着更美好的期许转向研究中药。 Due to the application of new analytical tools, there has been another boom in Chinese medicine R&D. In recent years, pharmaceutical companies have shifted from developing “bombshell” drugs that target individual molecules that cause a disease to the development of “complex” drugs that consist of multiple active ingredients. Although some people are still devoting themselves to researching and combining traditional medicines, some researchers have turned to Chinese medicine with better expectations.